Demerol (meperidine), chemically known as ethyl 1-methyl-4-phenylisonipecotate hydrochloride, is an opioid pain medication. Meperidine is used to treat moderate-to-severe pain.
An opioid is sometimes referred to as narcotics. Opioids are drugs that act on the nervous system to relieve pain. The term opioid refers to all substances (exogenous or endogenous) with morphine-like properties.

Market Analysis and Insights: Global Demerol (Meperidine) Market
In 2020, the global Demerol (Meperidine) market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% between 2021 and 2027
Global Demerol (Meperidine) Scope and Market Size
The global Demerol (Meperidine) market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Demerol (Meperidine) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.

Segment by Type
Powder
Liquid

Segment by Application
Anesthesia
Cough Treatment
Diarrhea Treatment

By Company
Purdue Pharma
Egalet
Boehringer Ingelheim
Janssen
Sanofi
Sun Pharmaceuticals
Mallinckrodt Pharmaceuticals
Endo Pharmaceuticals
Actavis
Pfizer

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE